Virus News and Research

Latest Virus News and Research

Enisamium shows potential as antiviral therapy for COVID-19

Researchers studied the effect of enisamium on the growth and proliferation of Caco-2 and normal human bronchial epithelial cells.

6 Oct 2021

Rapid molecular assay to detect SARS-CoV-2-specific RNA sequences

The study reported rapid detection of SARS-CoV-2 with high sensitivity and specificity in clinical samples.

6 Oct 2021

Transmission of SARS-CoV-2 during a 2-hour domestic flight

A new study investigated a cluster of COVID-19 infections among travelers who were likely exposed to an index patient in an airplane.

6 Oct 2021

Comparative analysis between the SARS-CoV-1 and SARS-CoV-2 mPro systems

To better understand the biophysical changes that occur due to mutations, the mechanisms of multiple SARS-CoV-2 proteins have been studied and compared with SARS-CoV-1.

6 Oct 2021

SARS-CoV-2 emerging variants display enhanced syncytia formation

Researchers compared the replication and syncytia forming potential of Alpha, Beta, and D614G strains in human cell lines and primary airway cells.

6 Oct 2021

What is the frequency of COVID testing to prevent Delta variant transmission?

In a new study published on the medRxiv* preprint server, scientists have used available data on the Delta variant’s viral load to infer its infectiousness and, subsequently, estimate the reduction in its transmission brought about by surveillance testing. The testing, done at different frequencies, was performed on a susceptible population. The cases of both the original Wuhan strain and the Delta variant were considered.

6 Oct 2021

University of Washington partners with USAID to better identify and prevent future pandemics

Randy CarnellLaboratory medicine scientists look through the window of equipment used in analyzing virus samples.

6 Oct 2021

UTHSC receives $3.2 million to upgrade the Regional Biocontainment Laboratory

The University of Tennessee Health Science Center has been awarded $3.2 million from the National Institute of Allergy and Infectious Diseases (NIAID) to upgrade the equipment and infrastructure in the UTHSC Regional Biocontainment Laboratory (RBL) on the Memphis campus to enhance the university's research of infectious diseases, including COVID-19.

6 Oct 2021

Autoimmune disease drug helps prevent lung damage, death in mice with SARS-CoV-2 infection

In a new paper, researchers at the University of Illinois Chicago report that a drug approved for treating patients with autoimmune disease helped to prevent lung damage and death in mice infected with the SARS-CoV-2 virus, which causes COVID-19 in humans.

6 Oct 2021

Acute myocarditis extremely rare after COVID mRNA vaccination in adults

Now, a new study published in the journal JAMA Internal Medicine evaluated the incidence of acute myocarditis and clinical outcomes among adults who received the mRNA vaccine in an integrated health care system in the United States.

5 Oct 2021

Research highlights challenges in utilizing Ct data to guide COVID-19 clinical planning

In a new study, a collaboration of researchers from various institutes described the natural history of SARS-CoV-2 testing, which includes Ct values among patients who had tested positive multiple times, prior to the emergence of VOCs in the vaccine roll-out. In addition, the authors analyze the timescale of positivity and clinical features of the population of patients with prolonged SARS-CoV-2 positivity.

5 Oct 2021

SARS-CoV-2 variants of concern more virulent than the native strain of the virus

A large study from Ontario confirms that SARS-CoV-2 variants of concern (VOCs), especially the Delta variant, are more virulent than the native strain of the virus, increasing people's risk of hospitalization, admission to the intensive care unit (ICU) and death due to COVID-19.

5 Oct 2021

Cysteamine inhibits SARS-CoV-2 variants of concern in vitro

Researchers in the United States have shown that a compound currently used to treat cystinosis exhibits broad antiviral activity against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

5 Oct 2021

Plasmid DNA vaccines induce effective antibody responses against SARS-CoV-2 in mice

Researchers in the United States and China have developed plasmid DNA immunogens that induce effective antibody responses in mice against the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

5 Oct 2021

COVID-19 survivors under 40 more likely to recover from smell and taste loss, study finds

Sense of smell or taste returns within six months for 4 out of every 5 COVID-19 survivors who have lost these senses, and those under 40 are more likely to recover these senses than older adults, an ongoing Virginia Commonwealth University study found.

5 Oct 2021

Virus News and Research

Latest Virus News and Research

Enisamium shows potential as antiviral therapy for COVID-19

Rapid molecular assay to detect SARS-CoV-2-specific RNA sequences

Transmission of SARS-CoV-2 during a 2-hour domestic flight

Comparative analysis between the SARS-CoV-1 and SARS-CoV-2 mPro systems

SARS-CoV-2 emerging variants display enhanced syncytia formation

What is the frequency of COVID testing to prevent Delta variant transmission?

University of Washington partners with USAID to better identify and prevent future pandemics

UTHSC receives $3.2 million to upgrade the Regional Biocontainment Laboratory

Autoimmune disease drug helps prevent lung damage, death in mice with SARS-CoV-2 infection

Acute myocarditis extremely rare after COVID mRNA vaccination in adults

Research highlights challenges in utilizing Ct data to guide COVID-19 clinical planning

SARS-CoV-2 variants of concern more virulent than the native strain of the virus

Cysteamine inhibits SARS-CoV-2 variants of concern in vitro

Plasmid DNA vaccines induce effective antibody responses against SARS-CoV-2 in mice

COVID-19 survivors under 40 more likely to recover from smell and taste loss, study finds

AstraZeneca COVID-19 vaccine safe and effective in phase 3 U.S., Chile, and Peru trial

A possible protective genetic polymorphism in COVID-19

Anti-nucleocapsid SARS-Cov-2 antibodies wane over time in long-term care facilities

SARS-CoV-2 beta variant elicits variant specific and cross-reactive antibodies

Emergence and evolution of endemic and emerging coronavirus diversity in humans and animals

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in